In order to understand the mechanisms involved in breast cancer in diabetic and obese patients and to look for a potential target therapy, we will investigate whether the hyperinsulinemia state in diabetic or obese patients promotes more frequently GLUT-1 overexpressing cancers. The gene discussed is SLC2A1; the disease is breast carcinoma.